•
BM
BMRN
BioMarin Pharmaceuticals Inc
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
10.91B
Volume
1.44M
52W High
$73.51
52W Low
$50.76
Open
$0.00
Prev Close
$56.31
Day Range
0.00 - 0.00
About BioMarin Pharmaceuticals Inc
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
Latest News
10 Magnificent Stocks That Can Make You Richer in 2026
The Motley Fool•Jan 5
Silver Breaks Above $70, Novo Nordisk Soars 9% On Obesity Pill Approval: What's Moving Markets Tuesday? (CORRECTED)
Benzinga•Dec 24
What's Going On With BioMarin Stock On Tuesday?
Benzinga•Dec 23
Pulmonary Emphysema Market Set to Expand by 2034 with Rising COPD Prevalence and Therapeutic Innovation | DelveInsight
GlobeNewswire Inc.•Nov 3
AAV Gene Therapy Market Size to Skyrocket at 40.1% CAGR by 2034
GlobeNewswire Inc.•Oct 7
Pompe Disease Market Analysis Report 2025-2035: Enzyme Replacement Therapies and Approvals of Myozyme and Nexviazyme Drive Steady Growth
GlobeNewswire Inc.•Oct 1
Predicting the Next Rule Breaker Buyout
The Motley Fool•Aug 19
BioMarin Discontinues Preclinical Drug Candidate, Advances BMN 333 Toward 2030
Benzinga•Aug 5